While in untreated fibroblasts from sporadic PD patients the levels of PAR2 and SerpinB3 were higher than those observed in the controls, in genetic PD patients, the levels of these two molecules were similar to those observed in the controls. The gene discussed is F2RL1; the disease is Parkinson disease.